Vitamin D, PTH, and calcium and the risk of prostate cancer: a prospective nested case-control study (Q38432079)

3 September 2017

Vitamin D, PTH, and calcium and the risk of prostate cancer: a prospective nested case-control study (English)

1 reference

3 September 2017

0 references

1 reference

4

Johan Malm

1 reference

3 September 2017

Johan Brändstedt

1

1 reference

PubMed ID

22706676

3 September 2017

Martin Almquist

series ordinal

2

1 reference

PubMed ID

22706676

3 September 2017

Jonas Manjer

series ordinal

3

1 reference

3 September 2017

16 June 2012

1 reference

3 September 2017

Cancer Causes & Control

1 reference

3 September 2017

23

1 reference

3 September 2017

8

1 reference

3 September 2017

1377-1385

1 reference

https://scigraph.springernature.com/pub.10.1007/s10552-012-9948-3

3 September 2017

0 references

cites work

Calcitriol as a chemopreventive and therapeutic agent in prostate cancer: role of anti-inflammatory activity

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9948-3

Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: A longitudinal, nested case‐control study in the Nordic countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9948-3

Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9948-3

A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9948-3

Serum vitamin D metabolite levels and the subsequent development of prostate cancer (Hawaii, United States)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9948-3

Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9948-3

Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9948-3

Meta-analysis of longitudinal studies: Serum vitamin D and prostate cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9948-3

Effects of the calciotrophic peptides calcitonin and parathyroid hormone on prostate cancer growth and chemotaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9948-3

Extracellular calcium as a candidate mediator of prostate cancer skeletal metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9948-3

A prospective study of total and ionized serum calcium and fatal prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9948-3

Risk factors for prostate cancer incidence and progression in the health professionals follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9948-3

Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9948-3

Serum calcium and the risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9948-3

The Malmö Diet and Cancer Study: representativity, cancer incidence and mortality in participants and non-participants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9948-3

Serum vitamin D concentration and prostate cancer risk: a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9948-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9948-3

Intraindividual variation in serum thyroid hormones, parathyroid hormone and insulin-like growth factor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9948-3

Analytical quality goals for parathyroid hormone based on biological variation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9948-3

The completeness of the Swedish Cancer Register: a sample survey for year 1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9948-3

Vitamin D and calcium insufficiency-related chronic diseases: an emerging world-wide public health problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9948-3

Differences between men with screening-detected versus clinically diagnosed prostate cancers in the USA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9948-3

10.1007/S10552-012-9948-3

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference

PubMed ID

22706676